GenEmbryomics LTD Sample Contracts
GENEMBRYOMICS LIMITED UNDERWRITING AGREEMENT [ ] Ordinary SharesUnderwriting Agreement • March 25th, 2025 • GenEmbryomics LTD • Services-medical laboratories • New York
GenEmbryomics Limited, an Australian public company (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”, and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative shall have the same meaning as Underwriter as defined herein), an aggregate of 1,095,000 ordinary shares of the Company (the “Ordinary Shares”) and issue warrants to the Representative to purchase up to a total of [*] Ordinary Shares equal to (6%) of the Ordinary Shares sold in such offering in the form set forth in Exhibit A (the “Representative’s Warrant”). The Company also proposes to grant to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, an option (the “Over-allotment Option”) to
Memorandum of UnderstandingMemorandum of Understanding • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories
This Memorandum of Understanding ("MOU") is made and entered into as of 10th March 2025 by and between GenEmbryomics Limited ("GenEmbryomics") and Progenesis Inc ("Progenesis").
QUALIO ORDER FORM AND CUSTOMER AGREEMENTOrder Form and Customer Agreement • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories
This Order Form and Everworks Ltd’s Terms of Service (located at https://www.qualio.com/docs/terms) (together, the “Agreement”) is made between the customer named below (“Customer”) and Everworks Limited T/A Qualio, a company registered under the laws of Ireland with registered number 508152 and having its registered office at 13-18 City Quay, Dublin D02 ED70, Ireland(“Qualio”) and sets forth the terms and conditions upon which Everworks Ltd will supply Products (as defined in the Terms of Service) to Customer (each a “Party” and together the “Parties”).
Memorandum of UnderstandingMemorandum of Understanding • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories
This Memorandum of Understanding ("MOU") is made and entered into as of [DATE] by and between GenEmbryomics Limited ("GenEmbryomics") and Progenesis Inc ("Progenesis").
Sale and Purchase Agreement of License RightsSale and Purchase Agreement of License Rights • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories
ILLUMINA SOFTWARE SUBSCRIPTION AGREEMENTIllumina Software Subscription Agreement • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories • California
This Illumina Software Subscription Agreement (together with any Service Addenda (as defined below), the “Agreement”) defines the rights and obligations of Illumina, Inc. (together with any of its affiliates that are identified on the quotation for Services (as defined below), “Illumina”) and the Customer (as defined below) regarding the Illumina software-as-a-service or on-premises software that is purchased on a subscription basis by Customer pursuant to any Illumina-issued quotation referencing this Agreement (each, a “Service”). This Agreement is a master agreement and will be accompanied by one or more applicable Service-specific addenda to this Agreement (each, a “Service Addendum”). This Agreement, each applicable Service Addendum, any quotation related to any Service, and any Privacy Documents (as defined below) constitute the entire agreement of the parties relating to the Services.
consulting services agreementConsulting Services Agreement • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories
Early adopter agreementEarly Adopter Agreement • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories • New York
Background A. We are a leading genomics services company committed to empowering families through innovative in-vitro fertilisation solutions by offering screening genetic diseases in embryos.
Development and Transfer Agreement for Genetic Analysis SystemsDevelopment and Transfer Agreement • March 17th, 2025 • GenEmbryomics LTD • Services-medical laboratories